Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients

被引:1
|
作者
Li, Xiang [1 ]
Fu, Gui-Fen [2 ]
Huang, Yu-Ying [1 ]
Jiang, Qing-Yu [1 ]
Huang, Xiao-Yan [1 ]
Zhang, Jin-Tao [1 ]
Qu, Shen-Hong [1 ]
机构
[1] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Otorhinolaryngol, Nanning, Peoples R China
[2] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Nursing, Nanning, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; chemoradiotherapy; symptom clusters; nursing; otorhinolaryngology; PERIODONTAL-DISEASE; RADIATION-THERAPY; CANCER PATIENTS; MUCOSITIS; HEAD;
D O I
10.3389/fonc.2023.920889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo investigate the incidence of complications and types of chemoradiotherepy induces symptom clusters in patients with nasopharyngeal carcinoma (NPC) who were first diagnosed after treatment and discharged from hospital. MethodsAfter their discharge home, 130 NPC patients who had been treated with chemoradiotherapy were asked to complete a modified Chinese version of the Quality of Life Questionnaire-Head and Neck Module developed by the European Organization for the Research and Treatment of Cancer in the Head and Neck. Symptom clusters in patients were identified through exploratory factor analysis. ResultsThe most serious symptoms for discharged NPC patients who had received chemoradiotherapy were dental problems, a sense of obstruction while swallowing, embarrassment in physical contact with family members and friends, difficulty in speaking with others, and embarrassment in public. The six symptom clusters identified through exploratory factor analysis were (1) painful eating, (2) social difficulties, (3) psychological disorders, (4) symptomatic shame, (5) teeth/throat injuries, and (6) sensory abnormalities. The total contribution rate of variance was 65.73%. ConclusionNPC patients who are treated with chemoradiotherapy can experience adverse symptom clusters that continue after discharge. Nurses should evaluate the patients' symptoms before discharge and provide targeted health education services which would reduce the patients' complications and improve the quality of life at home. Besides, medical staff should evaluate the complications in a timely and comprehensive manner and provide individualized health education for the affected patients to help them manage chemoradiotherapy side effects.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Symptom clusters in patients with nasopharyngeal carcinoma during radiotherapy
    Xiao, Wenli
    Chan, Carmen W. H.
    Fan, Yuying
    Leung, Doris Y. P.
    Xia, Weixiong
    He, Yan
    Tang, Linquan
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2017, 28 : 7 - 13
  • [2] Analysis of symptom clusters in Chinese cervical cancer patients undergoing radiotherapy, chemoradiotherapy, or postoperative chemoradiotherapy
    Wang, C. L.
    Wu, W. Y.
    Lou, H. M.
    Wang, H. M.
    Liang, G. M.
    Xia, L. Y.
    Fang, Y.
    Yin, Z. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (03) : 398 - 403
  • [3] Risk factor analysis and development of predictive models for osteoradionecrosis in patients with nasopharyngeal carcinoma after concurrent chemoradiotherapy
    Gong, Ming-Jie
    Lai, Zhi-Gang
    Zhang, Yun-Xia
    Hu, Na
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (10): : 4760 - 4771
  • [4] Sleep in nasopharyngeal carcinoma patients before chemotherapy, after induction chemotherapy, and after concurrent chemoradiotherapy
    Mo, Yanlin
    Zhu, Xiaodong
    Lai, Xiaoying
    Li, Ling
    MEDICAL HYPOTHESES, 2020, 144
  • [5] Nasopharyngeal primitive neuroectodermal tumor after concurrent chemoradiotherapy for nasopharyngeal carcinoma: a case report
    Chen, Bo-Nien
    Wey, Shiuan-Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 10106 - 10110
  • [6] Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma
    Imano, Nobuki
    Murakami, Yuji
    Nakashima, Takeo
    Takeuchi, Yuki
    Takahashi, Ippei
    Doi, Yoshiko
    Nishibuchi, Ikuno
    Kimura, Tomoki
    Wadasaki, Koichi
    Ueda, Tsutomu
    Hirakawa, Katsuhiro
    Nagata, Yasushi
    JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (11) : 673 - 680
  • [7] Analysis of Quality of Life Outcome for Nasopharyngeal Carcinoma Patients After Treatment
    Jakob, M.
    Manz, M.
    Schroeck, A.
    Bootz, F.
    Eichhorn, K.
    LARYNGO-RHINO-OTOLOGIE, 2013, 92 (04) : 244 - 250
  • [8] Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy
    Xiao, Canhua
    Hanlon, Alexandra
    Zhang, Qiang
    Ang, Kian
    Rosenthal, David I.
    Nguyen-Tan, P. Felix
    Kim, Harold
    Movsas, Benjamin
    Bruner, Deborah Watkins
    ORAL ONCOLOGY, 2013, 49 (04) : 360 - 366
  • [9] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
    Komatsu, Masanori
    Arai, Yasuhiro
    Yabuki, Kenichiro
    Sano, Daisuke
    Shiono, Osamu
    Sakuma, Yasunori
    Nishimura, Goushi
    Takahashi, Masahiro
    Taguchi, Takahide
    Oridate, Nobuhiko
    ANTICANCER RESEARCH, 2015, 35 (12) : 6861 - 6867
  • [10] Comparison of Concurrent Chemoradiotherapy versus Induction Chemotherapy Followed by Radiation in Patients with Nasopharyngeal Carcinoma
    Komatsu, Masanori
    Tsukuda, Mamoru
    Matsuda, Hideki
    Horiuchi, Choichi
    Taguch, Takahide
    Takahashi, Masahiro
    Nishimura, Gohshi
    Mori, Makiko
    Niho, Tatuo
    Ishitoya, Junichi
    Sakuma, Yasunori
    Hirama, Mariko
    Shiono, Osamu
    ANTICANCER RESEARCH, 2012, 32 (02) : 681 - 686